Preferred Label : MenACWY;
MeSH note : tetravalent CRM(197)-conjugated meningococcal vaccine (MenACWY) for infants;
Is substance : O;
Origin ID : C525703;
UMLS CUI : C2003457;
MeSH term(s) associated for indexing
- Record concept(s)
- See also (suggested by CISMeF)
- Semantic type(s)
http://www.has-sante.fr/portail/jcms/c_1032362/menveo-vaccin-meningococcique-a-c-w135-et-y-conjugue
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/menveo_-_ct-_8771.pdf
2014
France
French
child
antibiotic therapy
MenACWY
meningococcal vaccines
vaccines, conjugate
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
neisseria meningitidis, serogroup a
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
adolescent
adult
vaccination
meningococcal infections
injections, intramuscular
drug interactions
treatment outcome
meningococcal vaccines
vaccines, conjugate
MenACWY-CRM vaccine
guidelines for drug use
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/Menveo
2012
United Kingdom
English
French
syndication feed
vaccination
adult
adolescent
risk factors
meningococcal vaccines
meningococcal infections
drug approval
drug labeling
treatment outcome
MenACWY
injections, intramuscular
vaccines, conjugate
neisseria meningitidis, serogroup a
neisseria meningitidis, serogroup C
neisseria meningitidis, serogroup W-135
neisseria meningitidis, serogroup y
polysaccharides, bacterial
meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
drug interactions
pregnancy
breast feeding
meningococcal vaccines
vaccines, conjugate
MenACWY-CRM vaccine
package leaflet
summary of product characteristics
drug evaluation
---
